85-2066-22 IKKB-beta, Recombinant, Human, GST-His-IKK-B, Active 5ug 209023

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Three major forms of IKB like molecules have been identified and each is characterised by multiple copies of ankyrin repeats. IKB alpha and IKB beta appear to be the major regulatory forms of IKB in most cells. These proteins interact with p65 or cRel containing forms of NFkB and block nuclear import by masking the nuclear localisation sequences of NFkB. The activation of NFkB involves the inducible phosphorylation and subsequent degradation of IKB. Immunoblotting easily detects the hyperphosphorylated forms of IKB alpha, but not phosphorylated IKB beta. Interestingly, IKB alpha and IKB beta mediate different NFkB responses. IkB alpha appears to control more transient activation of NFkB in response to an inducer, while IKB beta controls a persistent response. Bcl3 interacts with p50 and p52 containing forms of NFkB, but rather than being an inhibitor it appears to function to stimulate transcription. The degradation of IKB is confirmed by immunoblotting..
  • IKK-beta also known as inhibitor of nuclear factor kappa-B kinase subunit beta is a protein that in humans is encoded by the IKBKB (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta) gene. IKK-beta is an enzyme that serves as a protein subunit of IB kinase, which is a component of the cytokine- activated intracellular signaling pathway involved in triggering immune responses. Its activity causes activation of a transcription factor known as Nuclear Transcription factor kappa-B or NF-B. Activated IKK-beta phosphorylates a protein called the inhibitor of NF-beta B, IB (IkB), which binds NF-B to inhibit its function. Phosphorylated IB is degraded via the ubiquitination pathway, freeing NF-B, and allowing its entry into the nucleus of the cell where it activates various genes involved in inflammation and other immune responses.
  • Source:Recombinant protein corresponding to human IKKB-beta, N-terminally fused to GST-His6-Thrombin cleavage site, expressed in sf9 cells.
  • Molecular Weight:~120kD
  • Activity:~6pmol/ug min
  • Applications:Suitable for use in Western Blot and Kinase Assays. Other applications not tested.
  • Recommended Dilution:Optimal dilutions to be determined by the researcher.
  • Storage and Stability:Aliquot to avoid repeated freezing and thawing and store at -70°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

  • Size:5ug
  • Source Antigen:Recombinant, sf9 cells
  • Grade:Highly Purified
  • Purity:Highly Purified (~95%)
  • Form:Supplied as a liquid in 50mM Tris-HCl, pH 8.0, 100mM sodium chloride, 5mM DTT, 4mM reduced glutathione, 20% glycerol.
  • Calc Applications Abbrev:WB
  • Molecular Weight Non Ab:120
  • EU Commodity Code:30021019
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-2066-22
型番
209023
入り数
1個
標準価格
205,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る